Back to search

Article

Factors Associated with COVID-19 Breakthrough Infection in the Pre-Omicron Era Among Vaccinated Patients with Rheumatic Diseases: A Cohort Study

2022-07-15

Abstract excerpt

<h4>Objective</h4> Rheumatic disease patients on certain immunomodulators are at increased risk of impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors associated with breakthrough infection among patients with rheumatic diseases. <h4>Methods</h4> We identified patients with rheumatic diseases being treated with immunomodulators in a large healthcare system who received at least two doses...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cef47828-84a6-5964-aa89-4276e400d25c
DOI
10.1101/2022.07.13.22277606
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Factors Associated with COVID-19 Breakthrough Infection in the Pre-Omicron Era Among Vaccinated Patients with Rheumatic Diseases: A Cohort StudyDOI 10.1101/2022.07.13.22277606
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseasesSemantic proximity
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort studySemantic proximity
SARS-CoV-2 Delta Breakthrough Infections in Vaccinated Patients with Immune-Mediated Inflammatory Diseases Using Immunosuppressants – Data from Two Controlled Prospective Cohort StudiesSemantic proximity
COVID-19 Infection and Efficacy of Vaccination in Patients with Rheumatic Diseases During Omicron Outbreak in South Korea: A Prospective Cohort StudySemantic proximity
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2Semantic proximity
A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine EffectivenessSemantic proximity
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to OmicronSemantic proximity
Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?Semantic proximity
Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individualsSemantic proximity
Covid 19 Infection in Patients with Rheumatic Immune-Mediated Diseases in a Single University Hospital. Matched Case-Control Study and Literature Review.Semantic proximity
Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugsSemantic proximity
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort studySemantic proximity
Select a neighboring publication to make it the new centre.